Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Rheumatic Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cardiovascular comorbidity in rheumatic diseases.Nat Rev Rheumatol. 2015; 11: 693-704
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.Ann Rheum Dis. 2012; 71: 1524-1529
- Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus.Autoimmun Rev. 2022; 21: 102925
- Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.Nat Rev Rheumatol. 2020; 16: 361-379
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.Ann Rheum Dis. 2017; 76: 17-28
- Systematic functional regulatory assessment of disease-associated variants.Proc Natl Acad Sci U S A. 2013; 110: 9607-9612
- Proinflammatory HLA-DRB1∗01-haplotype predisposes to ST-elevation myocardial infarction.Atherosclerosis. 2012; 221: 461-466
- HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.Arthritis Rheum. 2007; 57: 125-132
- Coronary Artery Calcification and Rheumatoid Arthritis: Lack of Relationship to Risk Alleles for Coronary Artery Disease in the General Population.Arthritis Rheumatol. 2017; 69: 529-541
- Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.Sci Rep. 2017; 7: 40303
- Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights.Expert Rev Clin Immunol. 2021; 17: 355-374
- Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.J Autoimmun. 2017; 82: 1-12
- Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.Arch Intern Med. 2005; 165: 1624-1629
- Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.Arthritis Rheum. 2004; 50: 3450-3457
- Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics.Arthritis Rheum. 2010; 62: 3173-3182
- Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?.Ann Rheum Dis. 2008; 67: 64-69
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.Ann Rheum Dis. 2011; 70: 482-487
- Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.J Autoimmun. 2022; 129: 102815
- Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.Ann Rheum Dis. 2017; 76: 1642-1647
- The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men.Heart. 2007; 93: 1263-1267
- Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.Arthritis Rheum. 2009; 61: 419-424
- Antibodies to citrullinated peptides and risk of coronary heart disease.Atherosclerosis. 2013; 228: 243-246
- Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease.Ann Rheum Dis. 2014; 73: 1797-1804
- Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid Arthritis.Arthritis Rheumatol. 2020; 72: 400-408
- Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions.Arthritis Rheumatol. 2020; 72: 1467-1475
- Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.Circulation. 2000; 101: 2883-2888
- Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.Am J Cardiol. 2012; 110: 420-424
- Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.Ann Rheum Dis. 2015; 74: 668-674
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.Arthritis Rheum. 2001; 44: 2331-2337
- Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.Rheumatology (Oxford). 2017; 56: 1102-1110
- Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.PLoS One. 2017; 12: e0174656
- Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study.Ann Rheum Dis. 2014; 73: 722-727
- A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus.ACR open Rheumatol. 2021; 3: 209-220
- Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.Arthritis Res Ther. 2020; 22: 282
- Imaging for screening cardiovascular involvement in patients with systemic rheumatologic diseases: more questions than answers.Eur Heart J Cardiovasc Imaging. 2019; 20: 967-978
- Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.Arthritis Rheum. 2011; 63: 1211-1220
- Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis.JAMA. 2012; 308: 796-803
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.Eur Heart J. 2020; 41: 111-188
- Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis.J Am Heart Assoc. 2017; 6
- A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.J Am Coll Cardiol. 2016; 68: 881-891
- Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases.RMD Open. 2017; 3: e000544
- Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease.Curr Rheumatol Rep. 2019; 22: 1
- Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.N Engl J Med. 2018; 379: 924-933
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019; 140: e596-e646
- Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.J Am Coll Cardiol. 2017; 69: 147-158
- Autoantibody against oxidised LDL and progression of carotid atherosclerosis.Lancet. 1992; 339: 883-887
- OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.Ann N Y Acad Sci. 2005; 1051: 313-322
- Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.Autoimmun Rev. 2018; 17: 366-375
- Risk factors for cardiovascular disease in systemic lupus erythematosus.Circulation. 2001; 104: 1887-1893
- Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus.Clin Immunol. 2014; 153: 1-7
- Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus.Rev Bras Reumatol. 2010; 50: 539-551
- Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.Adv Clin Exp Med. 2016; 25: 43-50
- High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.Cells. 2021; 10
- High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis.Atherosclerosis. 2020; 302: 36-42
- Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages.Exp Biol Med (Maywood). 2013; 238: 1192-1197
- Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.Int J Mol Sci. 2018; 19
- Atherosclerosis in rheumatoid arthritis: is it all about inflammation?.Nat Rev Rheumatol. 2015; 11: 390-400
- IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.Rheumatology (Oxford). 2020; 59: 407-417
- Establishing a Risk Prediction Model for Atherosclerosis in Systemic Lupus Erythematosus.Front Immunol. 2021; 12: 622216
- Machine Learning in Medicine.N Engl J Med. 2019; 380: 1347-1358
- An Introduction to Machine Learning.Clin Pharmacol Ther. 2020; 107: 871-885
- Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.Curr Atheroscler Rep. 2019; 21: 7
- Deep Learning in mHealth for Cardiovascular Disease, Diabetes, and Cancer: Systematic Review.JMIR Mhealth Uhealth. 2022; 10: e32344
- Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients.Rheumatol Int. 2022; 42: 215-239
- A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis.Rheumatology (Oxford). 2020; 59: 1767-1769
- Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario?.Clin Exp Rheumatol. 2019; 37 (Suppl 118(3)): 133-139
- Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis.J Cardiovasc Electrophysiol. 2019; 30: 1967-1976
- Deep Learning Algorithm to Detect Cardiac Sarcoidosis From Echocardiographic Movies.Circ J. 2021; 86: 87-95
- EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.Ann Rheum Dis. 2022; 81: 768-779
- ESC Guidelines on cardiovascular disease prevention in clinical practice.Eur Heart J. 2021; 42: 3227-3337
- SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.Eur Heart J. 2021; 42: 2439-2454
- SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.Eur Heart J. 2021; 42: 2455-2467
- ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2014; 63: 2935-2959
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.Arthritis Rheum. 2008; 59: 1690-1697
- Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.Arthritis Care Res (Hoboken). 2010; 62: 362-370
- The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.Arthritis Rheum. 2005; 52: 412-420
- Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006.J Intern Med. 2010; 268: 578-585
- Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?.J Rheumatol. 2017; 44: 732-739
- No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.Clin Exp Rheumatol. 2015; 33: 391-398
- Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients.Arthritis Care Res (Hoboken). 2020; 72: 1431-1439
- The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.Rheumatology (Oxford). 2017; 56: 709-715
- Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies.Arthritis Care Res (Hoboken). 2017; 69: 67-74
- Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis.Ann Rheum Dis. 2019; 78: e57
- SAT0321 cardiovascular events in spondyloarthritis : a meta-analysis.Ann Rheum Dis. 2019; 78: 1239
- Systemic sclerosis and risk of cardiovascular disease: A PRISMA-compliant systemic review and meta-analysis of cohort studies.Medicine (Baltimore). 2020; 99: e23009
- Association between primary Sjögren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis.Clin Exp Rheumatol. 2018; 36 (Suppl 112(3)): 190-197
- Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.Rheumatology (Oxford). 2018; 57: 555-562
- An Updated Review of Cardiovascular Events in Giant Cell Arteritis.J Clin Med. 2022; 11
- Ischemic complications in Takayasu's arteritis: A meta-analysis.Semin Arthritis Rheum. 2018; 47: 900-906
- Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.Ann Rheum Dis. 2017; 76: 1396-1404
- High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.Rheumatology (Oxford). 2018; 57: 1080-1088
- Relationship between hsTnI and coronary stenosis in asymptomatic women with rheumatoid arthritis.BMC Cardiovasc Disord. 2016; 16: 184
- High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation.PloS one. 2012; 7: e38930
- Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study.Arthritis Rheumatol. 2022; 74: 1184-1192
- Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis.J Am Heart Assoc. 2020; 9: e017417
- High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.Arthritis Res Ther. 2017; 19: 132
- N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).Ann Rheum Dis. 2014; 73: 684-690
- Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus.Arthritis Rheum. 2012; 64: 316-317
- Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.Arthritis Res Ther. 2010; 12: R214
- Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis.Clin Rheumatol. 2010; 29: 1237-1243
- Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?.Clin Exp Rheumatol. 2018; 36 (Suppl 112(3)): 61-67
- Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis.Semin Arthritis Rheum. 2021; 51: 20-27
- Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.Rheumatology (Oxford). 2020; 59: 2847-2856
- HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis.Arthritis Res Ther. 2017; 19: 113
- The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis.Int J Mol Sci. 2021; 22
- OP0136 SERUM CHOLESTEROL LOADING CAPACITY ON MACROPHAGES AND INTERACTIONS WITH TREATMENTS ON CORONARY ATHEROSCLEROSIS BURDEN AND EVENT RISK IN RHEUMATOID ARTHRITIS.Ann Rheum Dis. 2022; 81: 87
- POS0596 serum cholesterol loading capacity on macrophages is linked to oxidized low-density lipoprotein and regulated by seropositivity and c-reactive protein in patients with rheumatoid arthritis.Ann Rheum Dis. 2022; 81: 565
- Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.J Clin Med. 2019; 8
- Hyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project.Clin Exp Rheumatol. 2019; 37: 774-782
- Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.Arthritis Care Res (Hoboken). 2015; 67: 442-446
- PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis.Front Cardiovasc Med. 2021; 8: 738764
- Elevation of serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus.Ann Transl Med. 2018; 6: 452
- Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis.Clin Exp Rheumatol. 2020; 38 (Suppl 125(3)): 18-24
- Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity.Rheumatology (Oxford). 2021; 60: 2296-2306
- Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.Clin Exp Rheumatol. 2016; 34: 1013-1019
- Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus.Lupus. 2020; 29: 825-835
- Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.Arthritis Rheum. 2005; 52: 2293-2299
- Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.Arthritis Res Ther. 2011; 13: R131
- Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.J Rheumatol. 1999; 26: 2562-2571
- IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.Semin Arthritis Rheum. 2015; 45: 18-27
- Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.PLoS One. 2015; 10: e0143153
- Predictors of Atherosclerosis in Ankylosing Spondylitis.Rheumatol Ther. 2015; 2: 173-182
- Atherosclerosis in Psoriatic Arthritis: A Multiparametric Analysis Using Imaging Technique and Laboratory Markers of Inflammation and Vascular Function.Int J Angiol. 2016; 25: 222-228
- Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2.Sci Rep. 2016; 6: 32116
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.